These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 25434496)

  • 1. Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.
    Kim S; Shin C; Jee SH
    Gene; 2015 Feb; 556(2):199-205. PubMed ID: 25434496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide association study identified novel genetic variant on SLC45A3 gene associated with serum levels prostate-specific antigen (PSA) in a Chinese population.
    Sun J; Tao S; Gao Y; Peng T; Tan A; Zhang H; Yang X; Qin X; Hu Y; Feng J; Kim ST; Lin X; Wu Y; Zhang J; Li Z; Li L; Mo L; Liang Z; Shi D; Huang Z; Huang X; Liu M; Liu Q; Zhang S; Lilly Zheng S; Xu J; Mo Z
    Hum Genet; 2013 Apr; 132(4):423-9. PubMed ID: 23269536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exome-based genome-wide association study and risk assessment using genetic risk score to prostate cancer in the Korean population.
    Oh JJ; Lee SJ; Hwang JY; Kim D; Lee SE; Hong SK; Ho JN; Yoon S; Sung J; Kim WJ; Byun SS
    Oncotarget; 2017 Jul; 8(27):43934-43943. PubMed ID: 28380453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide association study identifies novel single nucleotide polymorphisms having age-specific effect on prostate-specific antigen levels.
    Li W; Bicak M; Sjoberg DD; Vertosick E; Dahlin A; Melander O; Ulmert D; Lilja H; Klein RJ
    Prostate; 2020 Dec; 80(16):1405-1412. PubMed ID: 32914890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide association study of serum prostate-specific antigen levels based on 1000 Genomes imputed data in Japanese: the Japan Multi-Institutional Collaborative Cohort Study.
    Hishida A; Nakatochi M; Tamura T; Nagayoshi M; Okada R; Kubo Y; Tsukamoto M; Kadomatsu Y; Suzuki S; Nishiyama T; Kuriyama N; Watanabe I; Takezaki T; Nishimoto D; Kuriki K; Arisawa K; Katsuura-Kamano S; Mikami H; Kusakabe M; Oze I; Koyanagi YN; Nakamura Y; Kadota A; Shimanoe C; Tanaka K; Ikezaki H; Murata M; Kubo M; Momozawa Y; Takeuchi K; Wakai K;
    Nagoya J Med Sci; 2021 Feb; 83(1):183-194. PubMed ID: 33727749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.
    Knipe DW; Evans DM; Kemp JP; Eeles R; Easton DF; Kote-Jarai Z; Al Olama AA; Benlloch S; Donovan JL; Hamdy FC; Neal DE; Smith GD; Lathrop M; Martin RM
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1356-1365. PubMed ID: 24753544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Search for genetic factor association with cancer-free prostate-specific antigen level elevation on the basis of a genome-wide association study in the Korean population.
    Choe EK; Lee Y; Cho JY; Choi SH; Park B; Lee JE; Cho EY
    Eur J Cancer Prev; 2018 Sep; 27(5):453-460. PubMed ID: 28471803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic correction of PSA values using sequence variants associated with PSA levels.
    Gudmundsson J; Besenbacher S; Sulem P; Gudbjartsson DF; Olafsson I; Arinbjarnarson S; Agnarsson BA; Benediktsdottir KR; Isaksson HJ; Kostic JP; Gudjonsson SA; Stacey SN; Gylfason A; Sigurdsson A; Holm H; Bjornsdottir US; Eyjolfsson GI; Navarrete S; Fuertes F; Garcia-Prats MD; Polo E; Checherita IA; Jinga M; Badea P; Aben KK; Schalken JA; van Oort IM; Sweep FC; Helfand BT; Davis M; Donovan JL; Hamdy FC; Kristjansson K; Gulcher JR; Masson G; Kong A; Catalona WJ; Mayordomo JI; Geirsson G; Einarsson GV; Barkardottir RB; Jonsson E; Jinga V; Mates D; Kiemeney LA; Neal DE; Thorsteinsdottir U; Rafnar T; Stefansson K
    Sci Transl Med; 2010 Dec; 2(62):62ra92. PubMed ID: 21160077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancer.
    Chang BL; Hughes L; Chen DY; Gross L; Ruth K; Giri VN
    BJU Int; 2014 May; 113(5b):E150-6. PubMed ID: 23937305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genome-wide association study of serum levels of prostate-specific antigen in the Japanese population.
    Terao C; Terada N; Matsuo K; Kawaguchi T; Yoshimura K; Hayashi N; Shimizu M; Soga N; Takahashi M; ; Kotoura Y; Yamada R; Ogawa O; Matsuda F
    J Med Genet; 2014 Aug; 51(8):530-6. PubMed ID: 24919509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.
    Hoffmann TJ; Passarelli MN; Graff RE; Emami NC; Sakoda LC; Jorgenson E; Habel LA; Shan J; Ranatunga DK; Quesenberry CP; Chao CR; Ghai NR; Aaronson D; Presti J; Nordström T; Wang Z; Berndt SI; Chanock SJ; Mosley JD; Klein RJ; Middha M; Lilja H; Melander O; Kvale MN; Kwok PY; Schaefer C; Risch N; Van Den Eeden SK; Witte JS
    Nat Commun; 2017 Jan; 8():14248. PubMed ID: 28139693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of prostate cancer from prostate biopsy in Chinese men using a genetic score derived from 24 prostate cancer risk-associated SNPs.
    Jiang H; Liu F; Wang Z; Na R; Zhang L; Wu Y; Zheng J; Lin X; Jiang D; Sun J; Zheng SL; Ding Q; Xu J
    Prostate; 2013 Nov; 73(15):1651-9. PubMed ID: 23868750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication of the 10q11 and Xp11 prostate cancer risk variants: results from a Utah pedigree-based study.
    Camp NJ; Farnham JM; Wong J; Christensen GB; Thomas A; Cannon-Albright LA
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1290-4. PubMed ID: 19336566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms at 19q13.33 are associated with [-2]proPSA (p2PSA) levels and provide additional predictive value to prostate health index for prostate cancer.
    Huang D; Ruan X; Wu Y; Lin X; Huang J; Ye D; Gao Y; Ding Q; Xu D; Na R
    Prostate; 2021 Sep; 81(13):971-982. PubMed ID: 34254325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population.
    Oh JJ; Byun SS; Lee SE; Hong SK; Jeong CW; Kim D; Kim HJ; Myung SC
    Gene; 2014 Jan; 533(1):86-93. PubMed ID: 24120391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication study of 34 common SNPs associated with prostate cancer in the Romanian population.
    Jinga V; Csiki IE; Manolescu A; Iordache P; Mates IN; Radavoi D; Rascu S; Badescu D; Badea P; Mates D
    J Cell Mol Med; 2016 Apr; 20(4):594-600. PubMed ID: 26773531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.
    Wiklund F; Zheng SL; Sun J; Adami HO; Lilja H; Hsu FC; Stattin P; Adolfsson J; Cramer SD; Duggan D; Carpten JD; Chang BL; Isaacs WB; Grönberg H; Xu J
    Prostate; 2009 Mar; 69(4):419-27. PubMed ID: 19116992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of common prostate cancer risk variants in an unscreened Romanian population.
    Iordache PD; Mates D; Gunnarsson B; Eggertsson HP; Sulem P; Guðmundsson J; Benónísdóttir S; Csiki IE; Rascu S; Radavoi D; Ursu R; Staicu C; Calota V; Voinoiu A; Jinga M; Rosoga G; Danau R; Sima SC; Badescu D; Suciu N; Radoi V; Manolescu A; Rafnar T; Halldórsson BV; Jinga V; Stefánsson K
    J Cell Mol Med; 2018 Mar; 22(3):1574-1582. PubMed ID: 29266682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population.
    Marzec J; Mao X; Li M; Wang M; Feng N; Gou X; Wang G; Sun Z; Xu J; Xu H; Zhang X; Zhao SC; Ren G; Yu Y; Wu Y; Wu J; Xue Y; Zhou B; Zhang Y; Xu X; Li J; He W; Benlloch S; Ross-Adams H; Chen L; Li J; Hong Y; Kote-Jarai Z; Cui X; Hou J; Guo J; Xu L; Yin C; Zhou Y; Neal DE; Oliver T; Cao G; Zhang Z; Easton DF; Chelala C; ; ; Al Olama AA; Eeles RA; Zhang H; Lu YJ
    Oncotarget; 2016 Apr; 7(16):21393-403. PubMed ID: 26881390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphism and prostate cancer aggressiveness: a case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans.
    Bensen JT; Xu Z; Smith GJ; Mohler JL; Fontham ET; Taylor JA
    Prostate; 2013 Jan; 73(1):11-22. PubMed ID: 22549899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.